Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1985 Mar;44(3):189-93.
doi: 10.1136/ard.44.3.189.

A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis

R Hopkins, H A Bird, H Jones, J Hill, K E Surrall, C Astbury, A Miller, V Wright
Clinical Trial

A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis

R Hopkins et al. Ann Rheum Dis. 1985 Mar.

Abstract

Etretinate (Tigason) and ibuprofen have been compared in a double-blind controlled trial in psoriatic arthritis to see if we could confirm a specific action for this vitamin A derivative suggested from earlier uncontrolled studies. Eleven out of 20 patients completed 24 weeks of therapy with etretinate (up to 0.5 mg/kg/day) whereas only 1/20 patients completed 24 weeks of therapy with ibuprofen alone. Etretinate improved skin lesions, and this may have encouraged patients to persist with it. Improvement of statistical significance was seen for articular index in both groups. In addition significant improvement in ESR, haemoglobin, C-reactive protein, and histidine occurred in the etretinate group. The main side effects of etretinate (which may preclude its use at a higher dose in this condition) included cracked and dried lips and sore mouth.

PubMed Disclaimer

References

    1. Q J Med. 1968 Jul;37(147):393-406 - PubMed
    1. Lancet. 1983 Apr 16;1(8329):860-3 - PubMed
    1. Schweiz Med Wochenschr. 1979 Dec 15;109(48):1912-4 - PubMed
    1. Experientia. 1978 Sep 15;34(9):1105-19 - PubMed